Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience (Q40320546)
Jump to navigation
Jump to search
scientific article published on February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience |
scientific article published on February 2017 |
Statements
1 reference
Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience (English)
1 reference
Joy Varghese
1 reference
Chandan Kedarisetty
1 reference
Jayanthi Venkataraman
1 reference
Vijaya Srinivasan
1 reference
Thiruchunapalli Deepashree
1 reference
Mangerira Uthappa
1 reference
Kaliamurthy Ilankumaran
1 reference
Sanjay Govil
1 reference
Mettu Reddy
1 reference
Mohamed Rela
1 reference
1 February 2017
1 reference
16
1 reference
2
1 reference
247-254
1 reference
Identifiers
1 reference
1 reference